A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology

Giuseppina Novo, Alessia Pepe, Ines Monte, Christian Cadeddu, Christian Cadeddu, Carlo G. Tocchetti, Concetta Zito, Nicola Maurea, Rosalinda Madonna, Paolo Spallarossa, Pasquale Pagliaro, Giuseppe Mercuro, Donato Mele, Alessia Pepe

Risultato della ricerca: Articlepeer review

20 Citazioni (Scopus)

Abstract

The US National Cancer Institute estimates that cardiotoxicity (CTX) from target therapy refers mostly to four groups of drugs: epidermal growth factor receptor 2 inhibitors, angiogenic inhibitors, directed Abelson murine leukemia viral oncogene homolog inhibitors, and proteasome inhibitors. The main cardiotoxic side-effects related to antiepidermal growth factor receptor 2 therapy are left ventricular systolic dysfunction and heart failure. Angiogenesis inhibitors are associated with hypertension, left ventricular dysfunction/heart failure, myocardial ischemia, QT prolongation, and thrombosis. Moreover, other agents may be related to CTX induced by treatment. In this study, we review the guidelines for a practical approach for the management of CTX in patients under anticancer target therapy.
Lingua originaleEnglish
pagine (da-a)93-104
Numero di pagine12
RivistaJournal of Cardiovascular Medicine
Volume17
Stato di pubblicazionePublished - 2016

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Fingerprint Entra nei temi di ricerca di 'A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology'. Insieme formano una fingerprint unica.

Cita questo